
|Articles|November 10, 2022
Defining the 'Lab of the Future'
Author(s)LabVantage Solutions
There are three phases of digital transformation needed to reimagine business models, achieve better performance, and create long-term sustainable advantage. It starts with changing our labs—the technologies, processes, ways of working, and data solutions.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
2
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
3
FDA Approves Wegovy HD Injectable Under Accelerated Approval
4
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
5